A host-vector system was developed for molecular cloning in Bacillus megaterium and used to clone the structural and immunity genes for megacins A-216 and A-19213. Recombinant clones that expressed immunity only or both immunity to and production of each megacin were obtained. Restriction mapping of native megacinogenic plasmids and recombinant clones was used to contruct physical and genetic maps of megacinogenic plasmids pBM309 and pBM113. Limited sequence homology between pBM309 and pBM113 was detected by Southern blot hybridization and was mapped to, at most, a 6.4-kilobase-pair region of pBM309 and a 6.1-kilobase-pair region of pBM113.
Megacins are bacteriocins produced by Bacillus megaterium that are categorized as types A, B, or C on the basis of mode of action, activity spectrum, and response to UV or mitomycin C induction (5) . A-type megacins are a heterogenous class of bacteriocins in which synthesis can be specifically induced by low-level UV irradiation or mitomycin C treatment (5) . Megacins A-216 and A-19213 are distinct bacteriocins that exert phospholipase activity (12, 18) and are produced in much greater amounts than other A-type megacins after induction (6, 18) . The structural genes and specific immunity genes for megacin A-216 and megacin A-19213 are encoded on plasmids pBM309 (48 kilobase pairs [kb] ) and pBM113 (44 kb), respectively (17, 19) .
In an effort to study the genetic organization and regulation of megacin genes, we undertook the molecular cloning of the structural and immunity genes and related regulatory sequences for both megacins A-216 and A-19213. For several reasons, we chose to conduct the initial cloning in B. megaterium. First, we reasoned that expression of megacin genes was most likely in a homologous host known to express megacin structural and immunity genes carried on native megacinogenic plasmids (19) . If other, as yet unidentified, nonplasmid genes affect megacin regulation, the choice of a homologous host could be critical to ensure megacin gene expression as it naturally occurs. Second, selection for immunity for desired recombinants was available in B. megaterium. We have shown that megacin immunity can be used to isolate transformants for native megacinogenic plasmids (19) and we reasoned that this property could be used to select recombinant clones carrying either immunity genes alone or both immunity and structural genes. Neither Bacillus subtilis nor Escherichia coli is naturally sensitive to megacin A (11) , so that selection for immunity is not possible with either of these host systems. Third, B. megaterium protoplasts can be transformed at low efficiencies (2, 7, 19, 20) ; however, we have achieved sufficiently high transformation efficiencies for some plasmids to permit their direct use as cloning vehicles (see below).
In this report we describe the development of a host-vector system for cloning in B. megaterium and report the molecular cloning of both structural and immunity genes for megacins A- (4) , and pHV23 (10) were transformed into VT1660 and then isolated from VT1660, as described previously (19) . Plasmid pBD64 (3) could not be introduced into VT1660. Plasmid pBD64 was isolated from B. subtilis BD170(pBD64).
Restriction mapping. Restriction endonucleases were used by the method of Maniatis et al. (9) . Restriction maps of the vector plasmid pBC16 and the megacinogenic plasmids pBM113 and pBM309 were constructed by analysis of single and multiple digestion patterns and by the DNA hybridization technique described by Palmer (13) .
Cloning and transformation. T4 DNA ligase was used as described by Maniatis et al. (9) . Polyethylene glycol-mediated transformation was performed as described previously (19) , except that protoplasts were concentrated 50-fold rather than 10-fold before ligated DNA was added, and incubation for 1.5 h at 30°C was eliminated. Transformed protoplasts were allowed to regenerate as lawns on RHAF plates before selection for antibiotic resistance or megacin immunity. Selective levels in nutrient agar replica plates were as follows: tetracycline, 20 ,ug/ml; neomycin, 10 ,ug/ml; chloramphenicol, 20 p.g/ml; megacins, 100 endpoint units per plate.
Megacin screening, induction, and titration. Colonies isolated as tetracycline resistant (Tcr) or megacin immune (Meg'mm) were tested on agar plates for production of A-type megacins by overlayering with soft agar containing mitomycin C (1 ,ug/ml) and cells of the indicator strain 2165 (19) . Induction and titration of megacins from broth cultures were conducted as described previously (18) .
Southern hybridization. Plasmid DNA was 32P-labeled by nick-translation as described by Rigby et al. (16) . Restriction fragments were resolved by horizontal 0.7% agarose gel electrophoresis. DNA was blotted onto nitrocellulose and hybridized under high stringency as described by Maniatis et al. (9) . In some cases, reduced stringency of hybridization was achieved by increasing the buffer concentration of the final wash solution from 0.1x SSC (1x SSC is 0.15 M NaCl plus 0.015 M sodium citrate) to 3x SSC.
RESULTS
Cloning strategy for B. megaterium. Several plasmids carrying drug resistance determinants were transformed into B. megaterium VT1660 to assess their potential as cloning vectors. The Tcr plasmid pBC16 (1) yielded more than 105 transformants per ,ug of DNA and was approximately 100-fold more transformation efficient than pUB110 (4). A B. subtilis cloning vector pBD64 (3) and a B. subtilis-E. coli shuttle vector pHV23 (10) transformed VT1660 very poorly or not at all. Because of its greater transformation efficiency and the availability of an immunity selection that obviated the need for insertional inactivation, pBC16 was chosen as a cloning vector for B, megaterium. We constructed a restriction map of pBC16 for restriction endonucleases that cleaved the plasmid at one or two sites (Fig. 1 ). EcoRI cleaves pBC16 twice, generating a 3.0-kb A fragment and a 1.6-kb B fragment. Polak and Novick (14) have shown that the A fragment alone can be stably maintained and expresses tetracycline resistance in B. subtilis. We therefore considered either or both EcoRI sites as well as the unique BamHI and XbaI sites located within the EcoRI B fragment as potential cloning sites that would maintain the integrity of both the replicon and the Tcr gene.
Cloning megacin structural and immunity genes. Megacinogenic plasmid pBM309 or pBM113 and the vector plasmid pBCI6 were restricted, mixed, ligated, and transformed into B. megaterium VT1660. Transformants were selected for megacin immunity to obtain desired clones and for tetracycline resistance to assess the frequency of recombinant molecules. Some Tcr transformants were randomly screened for recombinant plasmids by modified Eckhardt gel electrophoresis (19) using EcoRI, we found that 35% of the Tcr transformants contained recombinant plasmids larger than pBC16. Another experiment with XbaI yielded 6% recombinants. Some recombinant plasmids contained inserts greater than 20 kb.
A restriction map for pBM113 and several clones obtained by immune selection that expressed either immunity alone or both immunity to and production of megacin A-19213 is shown in Fig. 2 pBM113 (Fig. 2) . The ClaI C and D fragments are oriented similarly in pBM113 and pBM113A2; thus, the ClaI E fragment is critical for structural gene expression. Cloning of the immunity and structural genes for megacin A-216 is summarized in Fig. 3 . Plasmids pVT210 and pVT28 encoded immunity only and contained the XbaI G fragment and G plus H fragments of pBM309, respectively. Plasmids pVT26 and pVT27 encoded both immunity to and production of megacin A-216. These plasmids contained five and four XbaI fragmcnts of pBM309. The unique PstI site in pVT279, a megacin A-19213 immunity plasmid, was used to clone the Pstl B fragnient of pBM309, yielding pVT65 which encoded both immunity to and production of megacin A-216. Plasmids pVT26, pVT27, and pVT65 contain the XbaI G, H, and E fragments (8.1-kb total) in common (Fig. 3) . Thus, sequences involved in megacin A-216 immunity and production appear to be limited to, at most, about 17% of pBM309. Properties of megacin-impmune and producer bacteria. Plasmids constructed in vitro that expressed either immunity alone or both immunity to and production of each megacin were tested quantitatively for megacin production, megacin sensitivity, and lysis after induction with mitomycin C ( molecules. Our results indicate that recombinant plasmids can be readily obtained in B. megaterium and that such recombinant plasmids can contain quite large inserts; pVT27 contained an 18.1-kb insert, pVT525 contained an 18.5-kb insert, and other cryptic plasmids contained inserts greater than 20 kb. In at least some cases, the copy number of recombinant plasmids appears to be subject to copy number control of pBC16. These attributes may prove useful for the cloning of other gene products of Bacillus species. This system has been recently used to clone the insecticidal toxin gene of Bacillus thuringiensis var. israelensis (V. Sekar and B. C. Carlton, Gene, in press). Analysis of a number of recombinant plasmids permitted the genetic mapping of native megacinogenic plasmids pBM113 and pBM309. All megacin A-19213-immune clones contained common DNA sequences from pBM113 (Fig. 2) . The smallest clone, pVT279, includes the EcoRI F fragment of pBM113, whereas other immunity clones include part of the F fragment, extending to the ClaI site within the F fragment. Because cloning at the PstI site did not insertionally inactivate the immunity gene, it appears likely that this gene is located within the 1.7 kb of DNA between the CIal and PstI sites of the EcoRI F fragment. Although endpoint sensitivity as a measure of immunity to megacins is, at best, semiquantitative, strains carrying pVT279 or pVT211 are nonetheless clearly more resistant than are wild types. Most likely this is related to gene dosage effects, although other explanations cannot be excluded until the immunity gene pVT65 is reflected in the amount of a. and 1 subunits (Fig. 4) . A substantial cryptic peptide from 216 is also encoded by pVT27 and pVT65 (Fig. 4, arrow) . The presence of a. and 1 subunits for megacin A-19213 in induced lysates of VT1660(pVT525) is demonstrated in Fig. 4 (lane 2) .
Sequence homology between megacinogenic plasmids pBM113 and pBM309. Plasmid pBM113 was nick-translated and hybridized against restriction fragments of pBM309 ( as well as to double-digestion fragments generated by digestion with SalI-XhoI and SalI-BglII, but failed to hybridize to either pBR322 or X DNA (lane 8). Hybridization to bands other than the BglII B fragment (lane 5) reflects incomplete digestion of pBM309 with BglII. The hybridizing fragments all overlap on the physical map of pBM309, and the homology is limited to, at most, 6.4 kb of pBM309 (Fig. 3) .
Plasmid pBM309 was also nick-translated and probed against restriction fragments of pBM113 (Fig. 6) . Specific hybridization to the BglII-B (lane 2) and a 6.1-kb StuI-XhoI double-digestion fragment (lane 3) of pBM113 was clearly observed only under relaxed stringency. No hybridization with, pBR322 or X DNA was seen. The region of pBM113 homologous with sequences of pBM309 is indicated on the physical map of pBM113 (Fig. 2) Riabchenko and Rostas have found that the PstI B fragment cloned in pBD9 failed to render cells inducible by mitomycin C, whereas we found that cells carrying the PstI B fragment cloned in pVT279 (i.e., pVT65) are fully inducible. Possibly, pBM113 DNA in pVT279 regulates the induction of megacin A-216 in cells carrying pVT65.
Limited sequence homology was detected between megacinogenic plasmids pBM113 and pBM309 and mapped to a 6.4-kb region of pBM309 and a 6.1-kb region of pBM113. No homology was found between sequences coding for either megacin production or immunity. This was not surprising since megacins A-216 and A-19213 are immunologically and structurally distinct proteins, and their respective immunity genes are specific for the homologous megacin only (18) . The deletion derivatives of pBM309 reported by Riabchenko and Rostas (15) have lost the sequences homologous with pBM113, and both pBM113A1 and pBM113A2 have lost the sequences homologous with pBM309, so that the homologous region is not necessary for the maintenance and replication of either native megacinogenic plasmid. The homology between pBM309 and pBM113 remains of unknown significance.
The construction of recombinant plasmids employing a replicon known to be stable in B. subtilis (1, 14) should permit the introduction of megacin genes into B. subtilis. In this heterologous host, we should be able to assess whether pVT26, pVT27, and pVT525 are sufficient to specify megacin synthesis or whether other currently unidentified B. megaterium gene products are necessary for, or affect, megacin gene expression. Experiments to address these questions are currently in progress.
